1. Depression in patients with head and neck cancer and a functional genetic polymorphism of the serotonin transporter gene. Gilbert J, Haman KL, Dietrich MS, Blakely RD, Shelton RC, Murphy BA (2012) Head Neck 34(3): 359-64
    › Primary publication · 21604315 (PubMed)
  2. Defective presynaptic choline transport underlies hereditary motor neuropathy. Barwick KE, Wright J, Al-Turki S, McEntagart MM, Nair A, Chioza B, Al-Memar A, Modarres H, Reilly MM, Dick KJ, Ruggiero AM, Blakely RD, Hurles ME, Crosby AH (2012) Am J Hum Genet 91(6): 1103-7
    › Primary publication · 23141292 (PubMed) · PMC3516609 (PubMed Central)
  3. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, McMahon DG, Ramamoorthy S, Daws LC, Sutcliffe JS, Blakely RD (2012) Proc Natl Acad Sci U S A 109(14): 5469-74
    › Primary publication · 22431635 (PubMed) · PMC3325657 (PubMed Central)
  4. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. Sakrikar D, Mazei-Robison MS, Mergy MA, Richtand NW, Han Q, Hamilton PJ, Bowton E, Galli A, Veenstra-Vanderweele J, Gill M, Blakely RD (2012) J Neurosci 32(16): 5385-97
    › Primary publication · 22514303 (PubMed) · PMC3342037 (PubMed Central)
  5. Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter. Combs S, Kaufmann K, Field JR, Blakely RD, Meiler J (2011) ACS Chem Neurosci 2(2): 75-81
    › Primary publication · 22778858 (PubMed) · PMC3369724 (PubMed Central)
  6. Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots. Kovtun O, Tomlinson ID, Sakrikar DS, Chang JC, Blakely RD, Rosenthal SJ (2011) ACS Chem Neurosci 2(7): 370-8
    › Primary publication · 22816024 (PubMed) · PMC3369746 (PubMed Central)
  7. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD (2011) Proc Natl Acad Sci U S A 108(9): 3785-90
    › Primary publication · 21282638 (PubMed) · PMC3048100 (PubMed Central)
  8. Natural and engineered coding variation in antidepressant-sensitive serotonin transporters. Ye R, Blakely RD (2011) Neuroscience : 28-36
    › Primary publication · 21893166 (PubMed) · PMC3850749 (PubMed Central)
  9. Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans. Kohli U, Hahn MK, English BA, Sofowora GG, Muszkat M, Li C, Blakely RD, Stein CM, Kurnik D (2011) Pharmacogenet Genomics 21(4): 171-8
    › Primary publication · 21412203 (PubMed) · PMC3065933 (PubMed Central)
  10. Genetic indeterminism, the 5-HTTLPR, and the paths forward in neuropsychiatric genetics. Blakely RD, Veenstra-VanderWeele J (2011) Arch Gen Psychiatry 68(5): 457-8
    › Primary publication · 21536974 (PubMed) · PMC3686479 (PubMed Central)